EFFECT OF ELIMINATION OF PHAGOCYTIC-CELLS BY LIPOSOMAL DICHLOROMETHYLENE DIPHOSPHONATE ON ASPERGILLOSIS VIRULENCE AND TOXICITY OF LIPOSOMAL AMPHOTERICIN-B IN MICE

被引:8
作者
MOONIS, M [1 ]
AHMAD, I [1 ]
BACHHAWAT, BK [1 ]
机构
[1] UNIV DELHI,LIPOSOME RES CTR,DEPT BIOCHEM,S CAMPUS,NEW DELHI 110021,INDIA
关键词
D O I
10.1093/jac/33.3.571
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The role of macrophages in the toxicity and efficacy of liposomal amphotericin B (L-Amp B) was studied in a murine aspergillosis model infection. Macrophages and polymorphonuclear phagocytes (PMN cells) were depleted in the liver and spleen of mice by the administration of liposome encapsulated dichloromethylene diphosphonate. Macrophage depletion had no effect on the lethality of Fungizone, a commercial deoxycholate preparation of Amp B, but significantly increased the lethality of L-Amp B (P < 0·01). Macrophage depletion led to an increase in the fungal loads in the lung, liver and kidney (P < 0·05) and to an increase in the virulence of aspergillosis (P < 0·05). Tissue distribution analysis of L-Amp B revealed that in macrophage/PMN-depleted mice there was a decrease in the concentration of Amp B in the liver, with concomitant increases in the circulation, spleen and lung, both in the uninfected and in the infected conditions. The results clearly demonstrate that depletion of macrophage/PMN cells increases the virulence of aspergillosis, as well as the toxicity of L-Amp B. Moreover, L-Amp B treatment does not improve the survival rate of macrophage/PMN-depleted mice subjected to aspergillosis challenge. © 1994 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:571 / 583
页数:13
相关论文
共 18 条
[1]  
AHMAD I, 1989, INDIAN J BIOCHEM BIO, V26, P351
[2]  
AHMAD I, 1990, BIOTECHNOL APPL BIOC, V12, P550
[3]   DESIGN OF LIPOSOMES TO IMPROVE DELIVERY OF AMPHOTERICIN-B IN THE TREATMENT OF ASPERGILLOSIS [J].
AHMAD, I ;
SARKAR, AK ;
BACHHAWAT, BK .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1989, 91 (1-2) :85-90
[4]  
CLAASSEN E, 1984, BIOCHIM BIOPHYS ACTA, V802, P428, DOI 10.1016/0304-4165(84)90360-X
[5]  
CLAASSEN E, 1986, J MICROENCAPSUL, V3, P109
[6]   MECHANISMS OF DESTRUCTION OF ASPERGILLUS-FUMIGATUS HYPHAE MEDIATED BY HUMAN-MONOCYTES [J].
DIAMOND, RD ;
HUBER, E ;
HAUDENSCHILD, CC .
JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (03) :474-483
[7]   LIPOSOMES AS CARRIERS OF ANTIMICROBIAL AGENTS [J].
LOPEZBERESTEIN, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (05) :675-678
[8]   ALTERED TISSUE DISTRIBUTION OF AMPHOTERICIN-B BY LIPOSOMAL ENCAPSULATION - COMPARISON OF NORMAL MICE TO MICE INFECTED WITH CANDIDA-ALBICANS [J].
LOPEZBERESTEIN, G ;
ROSENBLUM, MG ;
MEHTA, R .
CANCER DRUG DELIVERY, 1984, 1 (03) :199-205
[9]   QUANTITATION OF AMPHOTERICIN-B WITH USE OF HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
NILSSONEHLE, I ;
YOSHIKAWA, TT ;
EDWARDS, JE ;
SCHOTZ, MC ;
GUZE, LB .
JOURNAL OF INFECTIOUS DISEASES, 1977, 135 (03) :414-422
[10]   SELECTIVE DEPLETION OF LIVER AND SPLENIC MACROPHAGES USING LIPOSOMES ENCAPSULATING THE DRUG DICHLOROMETHYLENE DIPHOSPHONATE - EFFECTS ON ANTIMICROBIAL RESISTANCE [J].
PINTO, AJ ;
STEWART, D ;
VANROOIJEN, N ;
MORAHAN, PS .
JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 49 (06) :579-586